Search Results

There are 24428 results for: content related to: The effect of clinical trial participation versus non-participation on overall survival in men receiving first-line docetaxel-containing chemotherapy for metastatic castration-resistant prostate cancer

  1. You have free access to this content
    Taxane-containing regimens for metastatic breast cancer

    Intervention Review

    The Cochrane Library

    Davina Ghersi, Melina L Willson, Matthew Ming Ki Chan, John Simes, Emma Donoghue and Nicholas Wilcken

    Published Online : 10 JUN 2015, DOI: 10.1002/14651858.CD003366.pub3

  2. Chemotherapy for advanced gastric cancer

    Intervention Review

    The Cochrane Library

    Anna Dorothea Wagner, Nicholas LX Syn, Markus Moehler, Wilfried Grothe, Wei Peng Yong, Bee-Choo Tai, Jingshan Ho and Susanne Unverzagt

    Published Online : 29 AUG 2017, DOI: 10.1002/14651858.CD004064.pub4

  3. You have full text access to this OnlineOpen article
    Pharmacokinetics, dynamics and toxicity of docetaxel: Why the Japanese dose differs from the Western dose

    Cancer Science

    Volume 106, Issue 5, May 2015, Pages: 497–504, Hirotsugu Kenmotsu and Yusuke Tanigawara

    Version of Record online : 25 MAR 2015, DOI: 10.1111/cas.12647

  4. Docetaxel-Associated Epiphora

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 26, Issue 6, June 2006, Pages: 853–867, Dr. Polly E. Kintzel, Dr. Laura B. Michaud and Dr. Marianne K. Lange

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.26.6.853

  5. You have free access to this content
    Cytotoxic chemotherapy in the contemporary management of metastatic castration-resistant prostate cancer (mCRPC)

    BJU International

    Volume 116, Issue 1, July 2015, Pages: 17–29, Guru Sonpavde, Christopher G. Wang, Matthew D. Galsky, William K. Oh and Andrew J. Armstrong

    Version of Record online : 23 OCT 2014, DOI: 10.1111/bju.12867

  6. Taxanes for adjuvant treatment of early breast cancer

    Intervention Review

    The Cochrane Library

    Thomas Ferguson, Nicholas Wilcken, Rosemary Vagg, Davina Ghersi and Anna K Nowak

    Published Online : 17 OCT 2007, DOI: 10.1002/14651858.CD004421.pub2

  7. You have free access to this content
    Docetaxel reintroduction in patients with metastatic castration-resistant docetaxel-sensitive prostate cancer: a retrospective multicentre study

    BJU International

    Volume 106, Issue 7, October 2010, Pages: 974–978, Jean-Christophe Eymard, Stéphane Oudard, Gwenaelle Gravis, Jean-Marc Ferrero, Christine Theodore, Florence Joly, Frank Priou, Ivan Krakowski, Alain Zannetti, Laurence Thill and Philippe Beuzeboc

    Version of Record online : 14 SEP 2010, DOI: 10.1111/j.1464-410X.2010.09296.x

  8. Docetaxel increases antitumor efficacy of oncolytic prostate-restricted replicative adenovirus by enhancing cell killing and virus distribution

    The Journal of Gene Medicine

    Volume 12, Issue 6, June 2010, Pages: 516–527, Xiong Li, Youhong Liu, Yong Tang, Phipps Roger, Meei-Huey Jeng and Chinghai Kao

    Version of Record online : 17 MAY 2010, DOI: 10.1002/jgm.1462

  9. You have free access to this content
    Nonneutropenic febrile episodes associated with docetaxel-based chemotherapy in patients with solid tumors

    Cancer

    Volume 95, Issue 6, 15 September 2002, Pages: 1326–1333, John Souglakos, Athanaslos Kotsakis, Charalambos Kouroussis, Stylianos Kakolyris, Dimitrios Mavroudis, Konstadinos Kalbakis, Sofia Agelaki, John Vlachonikolis, Vassilis Georgoulias and George Samonis

    Version of Record online : 5 SEP 2002, DOI: 10.1002/cncr.10802

  10. You have free access to this content
    Docetaxel rechallenge after an initial good response in patients with metastatic castration-resistant prostate cancer

    BJU International

    Volume 115, Issue 5, May 2015, Pages: 744–752, Stéphane Oudard, Gero Kramer, Orazio Caffo, Lorraine Creppy, Yohan Loriot, Steinbjoern Hansen, Mats Holmberg, Frederic Rolland, Jean-Pascal Machiels and Michael Krainer

    Version of Record online : 29 DEC 2014, DOI: 10.1111/bju.12845

  11. You have free access to this content
    Rational indication for docetaxel rechallenge in metastatic castration-resistant prostate cancer

    BJU International

    Volume 110, Issue 11b, December 2012, Pages: E635–E640, Matthias M. Heck, Mark Thalgott, Margitta Retz, Petra Wolf, Tobias Maurer, Roman Nawroth, Georgios Hatzichristodoulou, Jürgen E. Gschwend and Hubert Kübler

    Version of Record online : 13 AUG 2012, DOI: 10.1111/j.1464-410X.2012.11364.x

  12. You have full text access to this Open Access content
    E10A, an adenovirus carrying human endostatin gene, in combination with docetaxel treatment inhibits prostate cancer growth and metastases

    Journal of Cellular and Molecular Medicine

    Volume 14, Issue 1-2, January-February 2010, Pages: 381–391, Peng Zhao, Rongcheng Luo, Jiangxue Wu, Fajun Xie, Hongli Li, Xia Xiao, Liwu Fu, Xiaofeng Zhu, Ranyi Liu, Yinghui Zhu, Zhihui Liang and Wenlin Huang

    Version of Record online : 13 OCT 2008, DOI: 10.1111/j.1582-4934.2008.00548.x

  13. The effect of docetaxel on developing oedema in patients with breast cancer: a systematic review

    European Journal of Cancer Care

    Volume 25, Issue 2, March 2016, Pages: 269–279, W. Hugenholtz-Wamsteker, C. Robbeson, J. Nijs, W. Hoelen and M. Meeus

    Version of Record online : 27 OCT 2014, DOI: 10.1111/ecc.12261

  14. Chemotherapy for hormone-refractory prostate cancer

    Intervention Review

    The Cochrane Library

    Mike Shelley, Craig Harrison, Bernadette Coles, John Stafforth, Timothy Wilt and Malcolm Mason

    Published Online : 18 OCT 2006, DOI: 10.1002/14651858.CD005247.pub2

  15. You have free access to this content
    Phase 2 study of neoadjuvant docetaxel plus bevacizumab in patients with high-risk localized prostate cancer

    Cancer

    Volume 118, Issue 19, 1 October 2012, Pages: 4777–4784, Robert W. Ross, Matthew D. Galsky, Phil Febbo, Marc Barry, Jerome P. Richie, Wanling Xie, Fiona M. Fennessy, Rupal S. Bhatt, Julia Hayes, Toni K. Choueiri, Clare M. Tempany, Philip W. Kantoff, Mary E. Taplin and William K. Oh

    Version of Record online : 26 JAN 2012, DOI: 10.1002/cncr.27416

  16. You have free access to this content
    Dasatinib combined with docetaxel for castration-resistant prostate cancer

    Cancer

    Volume 118, Issue 1, 1 January 2012, Pages: 63–71, John C. Araujo, Paul Mathew, Andrew J. Armstrong, Edward L. Braud, Edwin Posadas, Mathew Lonberg, Gary E. Gallick, Géralyn C. Trudel, Prashni Paliwal, Shruti Agrawal and Christopher J. Logothetis

    Version of Record online : 4 MAR 2011, DOI: 10.1002/cncr.26204

  17. Optimal sequencing of docetaxel and abiraterone in men with metastatic castration-resistant prostate cancer

    The Prostate

    Volume 75, Issue 15, November 1, 2015, Pages: 1814–1820, Benjamin L. Maughan, Xian C. Xhou, Daniel L. Suzman, Rosa Nadal, Sunakshi Bassi, Michael T. Schweizer and Emmanuel S. Antonarakis

    Version of Record online : 26 AUG 2015, DOI: 10.1002/pros.23064

  18. You have full text access to this OnlineOpen article
    Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study

    Thoracic Cancer

    Volume 7, Issue 2, March 2016, Pages: 207–214, Sun Min Lim, Byeong Bae Park, Keun-Chil Park, Hoon-Kyo Kim, Jong Seok Lee, Sung Hwa Bae, Seung-Sei Lee, Jin-Hyoung Kang, Se-Hoon Park, Gyeong-Won Lee, Hyo-Rac Lee, Jae Hong Seo, Yong Tae Kim, Sung Hyun Yang and Joo-Hang Kim

    Version of Record online : 1 NOV 2015, DOI: 10.1111/1759-7714.12315

  19. You have free access to this content
    Association of pretreatment neutrophil-to-lymphocyte ratio (NLR) and overall survival (OS) in patients with metastatic castration-resistant prostate cancer (mCRPC) treated with first-line docetaxel

    BJU International

    Volume 114, Issue 6b, December 2014, Pages: E11–E17, Philipp Nuhn, Ajay M. Vaghasia, Jatinder Goyal, Xian C. Zhou, Michael A. Carducci, Mario A. Eisenberger and Emmanuel S. Antonarakis

    Version of Record online : 14 FEB 2014, DOI: 10.1111/bju.12531

  20. You have free access to this content
    Current and emerging treatment modalities for metastatic castration-resistant prostate cancer

    BJU International

    Volume 107, Issue s2, April 2011, Pages: 13–20, Sergio Bracarda, Christopher Logothetis, Cora N. Sternberg and Stéphane Oudard

    Version of Record online : 7 MAR 2011, DOI: 10.1111/j.1464-410X.2010.10036.x